Health Care/Hospital

Neuragenex Expands to Open New Illinois Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

CHICAGO, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening of four new locations inIllinois. With its groundbreaking approach to chronic pain management that is drug-free and non-in...

2023-08-09 00:14 1309

Neuragenex Expands to Open New Georgia Locations, Giving More People Access to its Innovative Approach to Chronic Pain Management

ATLANTA, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening of theLawrenceville clinic location in Georgia. With its groundbreaking approach to chronic pain management that is drug-fr...

2023-08-09 00:13 1338

Neuragenex Expands to Open New Utah Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

SALT LAKE CITY, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening ofBluffdale and Lehi clinic locations in Utah. With its groundbreaking approach to chronic pain management that is d...

2023-08-09 00:13 1371

Neuragenex Expands to Open New Texas Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

VICTORIA and WACO, Texas, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening of theWaco and Victoria clinic locations inTexas. With its groundbreaking approach to chronic pain managem...

2023-08-09 00:03 1378

Vatech Announces Distribution Through Henry Schein to Help Oral Health Professionals Enhance Access to Cutting-Edge Imaging Solutions

HWASEONG, South Korea, Aug. 8, 2023 /PRNewswire/ -- Vatech, a global leader in the dental imaging market, has announced that its products will be distributed byHenry Schein, helping to expand the availability of its cutting-edge products for dental clinics inNorth America. Vatech's portfolio o...

2023-08-08 21:00 1706

MomMed S21 Breast Pump Receives Three Prestigious Industry Awards

-  The Choice of Modern Moms: MomMed Breast Pump Stands Out in the Market NEW YORK, Aug. 8, 2023 /PRNewswire/ -- MomMed , a renowned mother and baby brand, proudly announces that its flagship product, the S21 Breast Pump, has received three prestigious industry awards in 2023...

2023-08-08 21:00 1595

For those who are worried about bad breath, "Wedent" is released

Even the "Wedent" tongue cleaner function, where hygiene and safety are the top priority! SEOUL, South Korea, Aug. 8, 2023 /PRNewswire/ -- Wedent, which has developed and produced only the best oral care products to lead a healthy oral culture since its establishment in 2001, was finally selecte...

2023-08-08 20:00 1578

I-Mab to Report Mid-Year 2023 Financial Results, Business and Corporate Updates on August 17, 2023

ROCKVILLE, Md. and SHANGHAI, Aug. 8, 2023 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of pioneering immunotherapies, today announced that it will report business and corporate updat...

2023-08-08 20:00 1668

ALPINION Launches a High-Performance Portable Ultrasound Diagnostic Device, X-CUBE i9

SEOUL, South Korea, Aug. 8, 2023 /PRNewswire/ -- ALPINION MEDICAL SYSTEMS Co., Ltd. launched 'X-CUBE i9', a portable ultrasound diagnostic device, with dual batteries and probe connectors that has greatly enhanced the speed and efficiency of examinations.

2023-08-08 17:03 2160

Harbour BioMed Appoints Dr. Albert R. Collinson as Independent Non-Executive Director

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 8, 2023 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunolo...

2023-08-08 16:10 2718

Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by a Syndicate of Premier Healthcare Investors

* Oversubscribed transaction led by Vivo Capital and joined by leading healthcare investors including Adage Capital Partners LP, Exome Asset Management, Janus Henderson Investors, Logos Capital, OrbiMed, Pivotal Life Sciences, RA Capital Management and TCGX * $100 million financing upfront wi...

2023-08-07 23:14 3250

AI-based wastewater sampling predicts COVID pressure on hospitals

SYDNEY, Aug. 7, 2023 /PRNewswire/ -- New research shows it is possible to accurately predict hospital admission numbers due to COVID-19 up to four weeks in advance with an Artificial Intelligence (AI) based system using COVID wastewater sampling.

2023-08-07 21:13 1640

Jacobio Pharma Announces Breakthrough Therapy Designation from China CDE for KRAS G12C Inhibitor Glecirasib for the Treatment of Pancreatic Cancer

BEIJING, SHANGHAI and BOSTON, Aug. 7, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, today announced that Jacobio's in-house KRAS G12C inhibitor glecirasib was granted breakthrough therapy designation (BTD) by the Center for Drug ...

2023-08-07 20:03 2142

Polish Running Icon Edyta Lewandowska Joins Amazfit as Brand Ambassador for UTMB 2023

CUPERTINO, Calif, Aug. 7, 2023 /PRNewswire/ -- Amazfit , a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), a health technology company, is thrilled to announce a collaboration with esteemed Polish runner,Edyta Lewandowska, as she takes on the ult...

2023-08-07 20:00 1393

Brili8 has released sunscreen, a must-have item this summer! Direct operation from development to shipment

* Brilli8 was selected as the Top 30 of this year's 'Social Economy Enterprise Growth Intensive Support Project' SEOUL, South Korea, Aug. 7, 2023 /PRNewswire/ -- Brillie8 Co., Cosmetics company that started operating a skin care shop in 2003 and launched its brand Brilli8 in 2018, was finally s...

2023-08-07 20:00 877

JY Corporation launches pesticide-free certified enoki mushroom tea grown in Naju, Jeollanam-do

* The Ministry of SMEs and Startups finally selected 30 companies to participate in this year's "Social Economy Enterprise Growth Intensive Support Project." SEOUL, South Korea, Aug. 7, 2023 /PRNewswire/ -- JY Corporation, a food company that distributes high-quality food at low prices to consu...

2023-08-07 20:00 1211

Dr. Yoon, natural-derived sulfur soap that has been tested for human application and skin irritation

* 30 companies were selected to participate in the "Social Economy Enterprise Growth Intensive Support Project" this year SEOUL, South Korea, Aug. 7, 2023 /PRNewswire/ -- Gangseo Chemical Industrial Co. ,which has studied only soap and detergents for 50 years, was finally selected as one of 30 ...

2023-08-07 20:00 1055

DualityBio Expands Global Strategic Partnership with BioNTech to Accelerate Development of a Third Antibody-Drug Conjugate Therapeutics for Solid Tumors

SHANGHAI, Aug. 7, 2023 /PRNewswire/ -- Duality Biologics (Suzhou) Co. Ltd. ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate ("ADC") therapeutics to treat patients with cancer and autoimmune diseases, today announ...

2023-08-07 18:00 1331

BioCity announces FDA clearance of Investigational New Drug application for its first-in-class CD3/EGFR bispecific antibody

WUXI, China, Aug. 7, 2023 /PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a Phase 1 study of BC3448 (CD3/EGFR Bispecific antibody, BsAb). As a result, BioCity Biopharma will...

2023-08-07 16:14 1371

The eClinical Medicine of Lancet Published Phase 2 Results of Ivonescimab for the Treatment of NSCLC

HONG KONG, Aug. 7, 2023 /PRNewswire/ -- Akeso Inc. ("Akeso", the "Company"; 9926.HK), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, announced today that eClinical Medicine(IF:15.1), a sub-j...

2023-08-07 12:29 2075
1 ... 81828384858687 ... 277

Week's Top Stories